Literature DB >> 23643276

Identification of accurate reference genes for RT-qPCR analysis of formalin-fixed paraffin-embedded tissue from primary non-small cell lung cancers and brain and lymph node metastases.

Signe Søes1, Brita Singers Sørensen, Jan Alsner, Jens Overgaard, Henrik Hager, Lise Lotte Hansen, Lasse Sommer Kristensen.   

Abstract

Lung cancer is the most common cause of cancer-related deaths worldwide, and metastatic spread of the cancer rather than the primary tumor is the main cause of death. However, the molecular alterations of cancer cells leading to the formation of metastasis are poorly understood. This is partly a result of most solid tumor samples available for retrospective studies being archived as formalin-fixed paraffin-embedded (FFPE) specimens causing the nucleic acids to be highly degraded. Furthermore, stably expressed reference genes for normalization of gene expression data using reverse transcriptase quantitative PCR (RT-qPCR) have not been identified for combined analysis of primary lung tumors and the tissues where to the cancer metastasize. Using an optimized RT-qPCR workflow we have analyzed the expression of 23 candidate reference genes in a total of 54 FFPE specimens derived from primary Non-Small Cell Lung Cancer tumors, brain metastases, and lymph node metastases as well as normal lung, lymph node, and brain tissues. We show that every aspect of the workflow is highly reproducible, and the PUM1, TBP, and IPO8 genes were identified as the most stably expressed reference genes among the candidates, by using the GeNorm and NormFinder software programs. Furthermore, we demonstrate that commonly used reference genes such as ACTB (β-actin), GAPDH, and rRNA18S are less stably expressed in the studied samples. The presented workflow and the identified reference genes may facilitate more reliable gene expression studies in lung cancer using RNA from FFPE tissues.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  FFPE; Metastasis; NSCLC; Normalization; RT-qPCR; Reference genes

Mesh:

Substances:

Year:  2013        PMID: 23643276     DOI: 10.1016/j.lungcan.2013.04.007

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  16 in total

1.  ELMO3: a direct driver of cancer metastasis?

Authors:  Lasse Sommer Kristensen; Signe Søes; Lise Lotte Hansen
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

2.  Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms.

Authors:  Haichuan Hu; Zofia Piotrowska; Patricia J Hare; Huidong Chen; Hillary E Mulvey; Aislinn Mayfield; Sundus Noeen; Krystina Kattermann; Max Greenberg; August Williams; Amanda K Riley; Jarad J Wilson; Ying-Qing Mao; Ruo-Pan Huang; Mandeep K Banwait; Jeffrey Ho; Giovanna S Crowther; Lida P Hariri; Rebecca S Heist; David P Kodack; Luca Pinello; Alice T Shaw; Mari Mino-Kenudson; Aaron N Hata; Lecia V Sequist; Cyril H Benes; Matthew J Niederst; Jeffrey A Engelman
Journal:  Cancer Cell       Date:  2021-10-07       Impact factor: 31.743

3.  The importance of reference gene analysis of formalin-fixed, paraffin-embedded samples from sarcoma patients - an often underestimated problem.

Authors:  Ninna Aggerholm-Pedersen; Akmal Safwat; Steen Bærentzen; Marianne Nordsmark; Ole Steen Nielsen; Jan Alsner; Brita S Sørensen
Journal:  Transl Oncol       Date:  2014-12       Impact factor: 4.243

4.  Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the European Lung Cancer Working Party.

Authors:  Thierry Berghmans; Lieveke Ameye; Jean-Jacques Lafitte; Benoît Colinet; Alexis Cortot; Ingrid CsToth; Stéphane Holbrechts; Jacques Lecomte; Céline Mascaux; Anne-Pascale Meert; Marianne Paesmans; Michel Richez; Arnaud Scherpereel; Christian Tulippe; Luc Willems; Tiffany Dernies; Nathalie Leclercq; Jean-Paul Sculier
Journal:  Front Oncol       Date:  2015-01-28       Impact factor: 6.244

5.  Hypomethylation and increased expression of the putative oncogene ELMO3 are associated with lung cancer development and metastases formation.

Authors:  Signe Søes; Iben Lyster Daugaard; Brita Singers Sørensen; Andreas Carus; Manuel Mattheisen; Jan Alsner; Jens Overgaard; Henrik Hager; Lise Lotte Hansen; Lasse Sommer Kristensen
Journal:  Oncoscience       Date:  2014-05-23

6.  Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous Cervical Cancer Patients.

Authors:  Christina S Fjeldbo; Eva-Katrine Aarnes; Eirik Malinen; Gunnar B Kristensen; Heidi Lyng
Journal:  PLoS One       Date:  2016-05-31       Impact factor: 3.240

7.  Quantitative analysis of noncoding RNA from paired fresh and formalin-fixed paraffin-embedded brain tissues.

Authors:  Yehui Lv; Shiying Li; Zhihong Li; Ruiyang Tao; Yu Shao; Yijiu Chen
Journal:  Int J Legal Med       Date:  2019-12-01       Impact factor: 2.686

8.  Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma.

Authors:  Lasse Sommer Kristensen; Fazila Asmar; Konstantinos Dimopoulos; Mette Kathrine Nygaard; Derya Aslan; Jakob Werner Hansen; Elisabeth Ralfkiaer; Kirsten Grønbæk
Journal:  Oncotarget       Date:  2014-10-30

9.  Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations.

Authors:  Derya Aslan; Christian Garde; Mette Katrine Nygaard; Alexandra Søgaard Helbo; Konstantinos Dimopoulos; Jakob Werner Hansen; Marianne Tang Severinsen; Marianne Bach Treppendahl; Lene Dissing Sjø; Kirsten Grønbæk; Lasse Sommer Kristensen
Journal:  Oncotarget       Date:  2016-03-01

10.  Selection and validation of reference genes for normalization of quantitative real-time reverse transcription PCR analysis in Poria cocos (Schw.) Wolf (Fuling).

Authors:  Xin Zhang; Zhi-Chao Xu; Jiang Xu; Ai-Jia Ji; Hong-Mei Luo; Jing-Yuan Song; Chao Sun; Yuan-Lei Hu; Shi-Lin Chen
Journal:  Chin Med       Date:  2016-03-02       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.